Nasdaq 100 Rally May Lead Nikkei 225, ASX 200 Higher, Bitcoin Falls

The Nasdaq 100 climbed as the FDA approval of a drug targeting Alzheimer’s disease bolstered the biotechnology sector. Asia-Pacific markets look set to open mixed. Bitcoin plunged below $34k mark. Via DailyFX - Market News https://ift.tt/32vveVH